<DOC>
	<DOCNO>NCT00019565</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , PET MRI scan , may help measure patient 's response treatment . PURPOSE : This diagnostic trial study well PET and/or MRI scan work assess change tumor blood supply patient receive antiangiogenesis therapy .</brief_summary>
	<brief_title>PET and/or MRI Scans Assessing Tumor Response Patients Receiving Antiangiogenesis Therapy</brief_title>
	<detailed_description>OBJECTIVES : - Evaluate ability positron emission tomography ( PET ) ass effect therapy direct tumor vasculatures tumor blood flow tumor blood volume patient enrol treatment protocol evaluate therapeutic modality effect tumor associate vasculature . - Evaluate ability PET ass effect type therapy regimen tumor uptake fluorodeoxyglucose patient . - Evaluate ability magnetic resonance imaging ( MRI ) ass effect therapy direct tumor vasculature tumor blood flow tumor vascular density patient . - Compare finding PET and/or MRI obtain conventional CT patient population . OUTLINE : This diagnostic study conduct concurrently therapeutic modality study . Patients magnetic resonance image and/or positron emission tomography ( PET ) scan perform prior start therapy , 6 week 16 week follow initiation therapy , 6 week follow completion therapy . Each scan require 1-3 hour . Patients receive 3 different PET scan include tumor blood flow scan H2015 , tumor blood volume scan 11CO , glucose uptake scan fludeoxyglucose F 18 . PROJECTED ACCRUAL : A total 145 patient accrue study within 2 year .</detailed_description>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Eligible treatment protocol evaluate therapeutic modality may effect tumor associate vasculature Measurable evaluable disease standard CT MRI At least 1 lesion measure great 2 cm diameter PATIENT CHARACTERISTICS : Age : Over 18 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Creatinine great 2.0 mg/dL Other : Not pregnant nursing Negative pregnancy test No pacemaker , aneurysm clip , shrapnel injury , implantable electronic device Weight great 136 kilogram No sensitivity contrast agent control premedication PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>